GEM^®, GEM^® II, & GEM^® III Family of ICDs

• GEM^® III DR
• GEM^® III VR 
• GEM^® II
• GEM^®

GEM^® III DR

Enhanced tachyarrhythmia therapy, safety,
and convenience:

• Fewer unnecessary shocks for patients
• Greater device longevity (6.1 years using
  15% pacing and quarterly charges)
• Exclusive Patient Alert™ monitors system for five safety conditions and alerts patients to seek follow-up care if necessary
• Enhanced diagnostics make follow-up more efficient and effective
• Medtronic Vision® software and Quick Look™ home page simplify programming
  and follow-up

Proven PR Logic™ analyzes rate, pattern, regularity and AV dissociation to detect and classify arrhythmias and trigger device response:

• When tachyarrhythmia therapy is delivered, device has 95.2% Positive Predictive Value with enhanced PR Logic™ 
• When tachyarrhythmia therapy is withheld, device has 100% sensitivity that it is not needed

Available with
GEM III DR/VR

“We view remote telemetry, such as that provided by the CareLink Network, as the new standard of care for ICD patients. I expect the technology to increasingly change the way patients with implantable devices are cared for across the country.”

W. Ben Johnson, M.D., an electrophysiologist at the Des Moines-based Iowa Heart Center.

The Medtronic CareLink Network is transforming patient care with the first and only remote monitoring service for device patients and their clinics.

Learn more >